Dexcom G5 MOBILE User Manual page 32

Helping Your Diabetes Management
The Alarm/Alerts features (see Chapter 11) keep you aware of your glucose levels. Alerts
notify you when your glucose goes outside your target range or is rapidly falling or rising,
letting you take action before you get too low or too high. The Urgent Low Glucose Alarm
lets you know when you are dangerously or urgently low, going below 55 mg/dL. By taking
corrective measures, you lessen the time spent in your low/high range, while increasing time
in your targeted range (Battelino, 2011; Garg, 2005). If you are using the G5 Mobile to make
treatment decisions, make sure your Alerts are on. See Chapter 13 for Treatment Decisions.
Real-time CGM can help improve your A1C as well as improve the quality of your glucose
control. If your A1C is at or below 7%, using a CGM such as the Dexcom G5 helps reduce
hypoglycemia (Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study
Group, 2008).
Lowering your A1C, increasing your time in your target range while decreasing time in
low/high BG range is believed to reduce your risk of diabetes-related complications (Ohkubo,
1995).
Some people perceive an increase in their quality of life and peace of mind when using
real-time CGM (Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study
Group, 2010).
References:
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011). Effect of
Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes. Diabetes Care, 34(4),
795-800.
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2005).
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose
Sensor: A randomized controlled trial. Diabetes Care, 29(1), 44-50.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group,
Tamborlane, W. V., Beck, R. W., Bode, B. W., Buckingham, B., Chase, H. P., Clemons, R., ... &
Xing, D. (2008). Continuous glucose monitoring and intensive treatment of type 1 diabetes.
The New England Journal of Medicine, 359(14), 1464-1476.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010).
Quality-of-Life Measures in Children and Adults with Type 1 Diabetes. Diabetes Care, 33(10),
2175-2177.
Dexcom G5 Mobile System User Guide
Risks and Benefits
30